We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Aquinnah Pharmaceuticals has announced that it has been awarded a $3.4 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) to advance novel therapeutic drug candidates
Neuro biotech Aquinnah Pharmaceuticals has a new vice president of research: Travis Wager, Ph.D., who wore various hats during his 20-year tenure at Pfizer.